| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.80e-04 | 793 | 24 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 3.51e-04 | 1180 | 24 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 6.00e-04 | 1289 | 24 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.09e-03 | 171 | 24 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | channel activity | 3.30e-03 | 525 | 24 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.33e-03 | 526 | 24 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 5.43e-03 | 301 | 24 | 3 | GO:0022853 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 6.20e-03 | 627 | 24 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 7.58e-03 | 664 | 24 | 4 | GO:0008324 | |
| Domain | LMF | 1.58e-06 | 2 | 24 | 2 | IPR009613 | |
| Domain | TMPIT | 1.58e-06 | 2 | 24 | 2 | IPR012926 | |
| Domain | LMF1 | 1.58e-06 | 2 | 24 | 2 | PF06762 | |
| Domain | TMPIT | 1.58e-06 | 2 | 24 | 2 | PF07851 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 6.56e-05 | 681 | 16 | 6 | MM14985 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 6.60e-05 | 11 | 16 | 2 | MM15559 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 1.01e-04 | 736 | 16 | 6 | M27287 | |
| Pathway | REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES | 2.04e-04 | 19 | 16 | 2 | M27839 | |
| Pathway | WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION | 2.75e-04 | 22 | 16 | 2 | M48101 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 3.57e-04 | 25 | 16 | 2 | MM15562 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_REMODELING | 6.63e-04 | 34 | 16 | 2 | M27842 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 2.20e-03 | 62 | 16 | 2 | MM14686 | |
| Pathway | REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE | 3.19e-03 | 75 | 16 | 2 | M27032 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 5.49e-03 | 99 | 16 | 2 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 6.27e-03 | 106 | 16 | 2 | M27200 | |
| Pathway | REACTOME_TRNA_PROCESSING | 6.86e-03 | 111 | 16 | 2 | M27684 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 34465718 | ||
| Pubmed | TMEM120A and B: Nuclear Envelope Transmembrane Proteins Important for Adipocyte Differentiation. | 4.96e-07 | 2 | 25 | 2 | 26024229 | |
| Pubmed | Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. | 4.96e-07 | 2 | 25 | 2 | 17994020 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 2.54e-06 | 569 | 25 | 6 | 30639242 | |
| Pubmed | TACAN Is an Ion Channel Involved in Sensing Mechanical Pain. | 4.95e-06 | 5 | 25 | 2 | 32084332 | |
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 33084572 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | 4.17e-04 | 499 | 25 | 4 | 22810586 | |
| Interaction | LRRC55 interactions | 1.06e-06 | 66 | 24 | 4 | int:LRRC55 | |
| Interaction | AGPAT3 interactions | 3.37e-06 | 88 | 24 | 4 | int:AGPAT3 | |
| Interaction | SLC22A9 interactions | 1.16e-05 | 120 | 24 | 4 | int:SLC22A9 | |
| Interaction | LAMP3 interactions | 1.77e-05 | 486 | 24 | 6 | int:LAMP3 | |
| Interaction | ARF6 interactions | 4.98e-05 | 584 | 24 | 6 | int:ARF6 | |
| Interaction | SVOPL interactions | 7.43e-05 | 11 | 24 | 2 | int:SVOPL | |
| Interaction | CHRNB4 interactions | 8.39e-05 | 72 | 24 | 3 | int:CHRNB4 | |
| Interaction | HTR3C interactions | 1.52e-04 | 88 | 24 | 3 | int:HTR3C | |
| Interaction | TMX2 interactions | 1.54e-04 | 233 | 24 | 4 | int:TMX2 | |
| Interaction | HRAS interactions | 1.64e-04 | 725 | 24 | 6 | int:HRAS | |
| Interaction | C3AR1 interactions | 2.22e-04 | 100 | 24 | 3 | int:C3AR1 | |
| Interaction | POMK interactions | 2.75e-04 | 271 | 24 | 4 | int:POMK | |
| Interaction | TSPAN15 interactions | 2.95e-04 | 276 | 24 | 4 | int:TSPAN15 | |
| Interaction | NIPAL1 interactions | 3.27e-04 | 114 | 24 | 3 | int:NIPAL1 | |
| Interaction | SLC10A7 interactions | 4.01e-04 | 25 | 24 | 2 | int:SLC10A7 | |
| Interaction | TCTN2 interactions | 4.25e-04 | 304 | 24 | 4 | int:TCTN2 | |
| Interaction | FUT3 interactions | 4.68e-04 | 27 | 24 | 2 | int:FUT3 | |
| Interaction | RAB2A interactions | 4.72e-04 | 567 | 24 | 5 | int:RAB2A | |
| Interaction | AQP6 interactions | 5.79e-04 | 330 | 24 | 4 | int:AQP6 | |
| Interaction | WNT16 interactions | 5.79e-04 | 30 | 24 | 2 | int:WNT16 | |
| Interaction | HSD17B13 interactions | 5.97e-04 | 140 | 24 | 3 | int:HSD17B13 | |
| Interaction | TCTN3 interactions | 6.06e-04 | 334 | 24 | 4 | int:TCTN3 | |
| Interaction | RAB5C interactions | 6.11e-04 | 600 | 24 | 5 | int:RAB5C | |
| Interaction | UPK1A interactions | 7.29e-04 | 150 | 24 | 3 | int:UPK1A | |
| Interaction | CHRNA4 interactions | 8.64e-04 | 159 | 24 | 3 | int:CHRNA4 | |
| Interaction | REEP5 interactions | 8.97e-04 | 371 | 24 | 4 | int:REEP5 | |
| Interaction | SLC39A4 interactions | 9.28e-04 | 163 | 24 | 3 | int:SLC39A4 | |
| Interaction | CRELD1 interactions | 9.28e-04 | 163 | 24 | 3 | int:CRELD1 | |
| Interaction | JTB interactions | 9.31e-04 | 38 | 24 | 2 | int:JTB | |
| Interaction | TLCD3A interactions | 9.31e-04 | 38 | 24 | 2 | int:TLCD3A | |
| Interaction | WNT4 interactions | 1.19e-03 | 43 | 24 | 2 | int:WNT4 | |
| Interaction | TMEM139 interactions | 1.30e-03 | 45 | 24 | 2 | int:TMEM139 | |
| Interaction | YIPF3 interactions | 1.36e-03 | 186 | 24 | 3 | int:YIPF3 | |
| Interaction | LAMTOR1 interactions | 1.40e-03 | 722 | 24 | 5 | int:LAMTOR1 | |
| Interaction | SLC9A6 interactions | 1.42e-03 | 47 | 24 | 2 | int:SLC9A6 | |
| Interaction | ENPP6 interactions | 1.42e-03 | 47 | 24 | 2 | int:ENPP6 | |
| Interaction | SLC22A4 interactions | 1.49e-03 | 192 | 24 | 3 | int:SLC22A4 | |
| Interaction | VIPR2 interactions | 1.53e-03 | 194 | 24 | 3 | int:VIPR2 | |
| Interaction | A4GNT interactions | 1.61e-03 | 50 | 24 | 2 | int:A4GNT | |
| GeneFamily | Solute carriers | 1.97e-03 | 395 | 12 | 3 | 752 | |
| Drug | Vitamin K2 [11032-49-8]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.56e-05 | 192 | 24 | 4 | 4356_UP | |
| Drug | Fenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.85e-05 | 195 | 24 | 4 | 7432_DN | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 4.85e-05 | 195 | 24 | 4 | 3269_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 4.95e-05 | 196 | 24 | 4 | 1021_DN | |
| Drug | Nystatine [1400-61-9]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 4807_UP | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 1696_DN | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 4776_DN | |
| Drug | Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 4.95e-05 | 196 | 24 | 4 | 4409_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 5.04e-05 | 197 | 24 | 4 | 5589_DN | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 5.25e-05 | 199 | 24 | 4 | 3264_UP | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 5.25e-05 | 199 | 24 | 4 | 5471_UP | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 6.30e-04 | 161 | 24 | 3 | 3556_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.76e-04 | 173 | 24 | 3 | 1016_UP | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 9.72e-04 | 187 | 24 | 3 | 4989_DN | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 9.72e-04 | 187 | 24 | 3 | 6984_UP | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 9.72e-04 | 187 | 24 | 3 | 1662_UP | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; HL60; HT_HG-U133A | 9.87e-04 | 188 | 24 | 3 | 2490_DN | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.02e-03 | 190 | 24 | 3 | 952_UP | |
| Drug | Eburnamonine (-) [4880-88-0]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.02e-03 | 190 | 24 | 3 | 7154_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.02e-03 | 190 | 24 | 3 | 3172_DN | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.03e-03 | 191 | 24 | 3 | 3574_UP | |
| Drug | Alsterpaullone; Up 200; 10uM; PC3; HT_HG-U133A | 1.03e-03 | 191 | 24 | 3 | 7078_UP | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.05e-03 | 192 | 24 | 3 | 1829_UP | |
| Drug | Enilconazole [35554-44-0]; Down 200; 13.4uM; HL60; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 3139_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 2209_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 4286_DN | |
| Drug | Cefadroxil [50370-12-2]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 4161_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 2748_UP | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 3908_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 2055_UP | |
| Drug | Amoxapine [14028-44-5]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.06e-03 | 193 | 24 | 3 | 4996_UP | |
| Drug | CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 6417_DN | |
| Drug | Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 7479_DN | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 4139_UP | |
| Drug | Luteolin [491-70-3]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.08e-03 | 194 | 24 | 3 | 3379_UP | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 5885_UP | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 5631_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 7393_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 5878_UP | |
| Drug | 5140203; Down 200; 15uM; MCF7; HT_HG-U133A_EA | 1.10e-03 | 195 | 24 | 3 | 908_DN | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 5814_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 7539_DN | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 1704_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 2805_UP | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.10e-03 | 195 | 24 | 3 | 7451_DN | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 6744_DN | |
| Drug | Trapidil [15421-84-8]; Down 200; 19.4uM; HL60; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 3136_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 2113_DN | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 5636_DN | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 3121_DN | |
| Drug | Piroxicam [36322-90-4]; Down 200; 12uM; PC3; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 2089_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 7092_UP | |
| Drug | Monocrotaline [315-22-0]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 7127_DN | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; HL60; HG-U133A | 1.11e-03 | 196 | 24 | 3 | 1597_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 4423_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 5569_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 1679_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 7184_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 6844_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 3277_UP | |
| Drug | Calycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 2764_DN | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; PC3; HT_HG-U133A | 1.11e-03 | 196 | 24 | 3 | 4548_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 1515_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 1540_DN | |
| Drug | Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 6277_DN | |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 6077_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 1800_UP | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 3372_DN | |
| Drug | Levonordefrin [829-74-3]; Down 200; 21.8uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 7208_DN | |
| Drug | rosiglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.13e-03 | 197 | 24 | 3 | 1071_DN | |
| Drug | Pyrazinamide [ 98-96-4]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 2839_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 3550_DN | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; HL60; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 6139_DN | |
| Drug | Estriol [50-27-1]; Down 200; 13.8uM; HL60; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 6140_DN | |
| Drug | Propylthiouracil [51-52-5]; Down 200; 23.4uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 2837_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 6455_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 1806_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; HL60; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 2556_UP | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 7026_DN | |
| Drug | Conessine [546-06-5]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 2792_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 1497_DN | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 3798_DN | |
| Drug | Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 5044_DN | |
| Drug | SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 6909_DN | |
| Drug | Pimozide [2062-78-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 7132_DN | |
| Drug | Enalapril maleate [76095-16-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 7026_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 1634_DN | |
| Drug | CP-863187 [668981-07-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 7553_DN | |
| Drug | LY 294002; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.13e-03 | 197 | 24 | 3 | 2676_UP | |
| Drug | Chlorphensin carbamate [886-74-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.15e-03 | 198 | 24 | 3 | 2279_DN | |
| Drug | prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.15e-03 | 198 | 24 | 3 | 6552_UP | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.15e-03 | 198 | 24 | 3 | 3540_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.15e-03 | 198 | 24 | 3 | 6502_DN | |
| Disease | disorder of pharynx | 6.97e-04 | 46 | 25 | 2 | MONDO_0020592 | |
| Disease | oropharynx cancer | 6.97e-04 | 46 | 25 | 2 | EFO_1001931 | |
| Disease | osteoporosis | 1.75e-03 | 73 | 25 | 2 | EFO_0003882 | |
| Disease | preeclampsia | 1.99e-03 | 78 | 25 | 2 | EFO_0000668 | |
| Disease | trait in response to apixaban | 4.26e-03 | 115 | 25 | 2 | OBA_2050328 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 5.49e-03 | 131 | 25 | 2 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 5.49e-03 | 131 | 25 | 2 | C4552091 | |
| Disease | Juvenile arthritis | 5.49e-03 | 131 | 25 | 2 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 5.49e-03 | 131 | 25 | 2 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 5.82e-03 | 135 | 25 | 2 | C0087031 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 7.79e-03 | 157 | 25 | 2 | DOID:14330 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GFLLLLLYWMPEWRV | 41 | Q9H7F0 | |
| KPNVMVFIAELFWWF | 316 | Q5T5Y3 | |
| MRRGNISPAFWFLWL | 1 | E2RYF6 | |
| MGFWWILRFPVFLAI | 301 | P47871 | |
| WLKMTPFGFRRILNW | 1721 | P09848 | |
| PVFGVLWITVLLFFW | 11 | Q96FL9 | |
| WGMAFWIPFIYRGVR | 626 | Q99575 | |
| MVVFLYPFLKWWRDP | 146 | Q96IV6 | |
| LVPMLGLAAFRWIWS | 31 | Q96BQ5 | |
| IVIFFWVMLWFLGLQ | 101 | Q8N8J7 | |
| FAFFVWLFVCPWMRR | 226 | Q08357 | |
| MVLWILWRPFGFSGR | 1 | Q32P41 | |
| QSWMWRGLTFLLPFL | 261 | A0PK00 | |
| SWMWRGLTFLLPFLF | 266 | Q9BXJ8 | |
| LPFWLVRWLLFRLMF | 166 | Q9BU23 | |
| FRLVPLGWMSLWLFR | 176 | A6NGC4 | |
| FAMIGTIFLWIFWPS | 221 | Q9H310 | |
| LWLPWDRFFVMETII | 986 | Q6N022 | |
| TLPWASVLRVWDMFF | 531 | Q4KMP7 | |
| IMKFPWQWAFLLGFV | 206 | Q4ZJI4 | |
| VFGTRWKILWFIPFR | 236 | Q8IVQ6 | |
| LTPSIFIIMVWYWRR | 241 | Q5T9L3 | |
| MLRGPWRQLWLFFLL | 1 | Q9H497 | |
| RWFHFWGAPVTIFMG | 771 | Q8TD43 | |
| VLWGFRWLIFRIMLG | 206 | Q96S06 |